Alzheimer's Society UKDTN Lead Research Nurse

Detailed job description and main responsibilities

Please refer to the attached job description and person specification for full details of responsibilities.

• Work locally, regionally and nationally to deliver on the Alzheimer’s Society Research Nurse Strategy (2024) and UKDTN programme aims.
•  Act as a role model and clinical expert locally and nationally ensuring high standards of care and safety for research participants in complex early phase and all dementia research studies
•  Work to embed self within local and regional clinical and research teams to establish and facilitate effective referral pathways and increase opportunities for individuals affected by Mild Cognitive Impairment and / dementia to participate in early phase clinical trials.
•  Optimise use of the UKDTN model and collaborate with colleagues across the Alzheimer’s Society UKDTN Research Nurse network, UK wide UKDTN Centres, Memory Assessment Services and local Mental Health Trusts and Acute Trusts (including CUH) to promote research opportunities and facilitate research referrals from these sites.
•  The nature of early phase studies means compliance to GCP and phase 1 governance requirements are paramount to patient safety and research outcomes. The post-holder will lead in the roll-out of early phase trial related training, mentorship and education to support local colleagues and teams from other UKDTN centres to become ‘phase 1 ready’.
•    Demonstrate expert skills and knowledge in local and national early phase regulations and approvals, including site specific phase 1 processes.
•  Collaborate with the CPFT Associate Director of Research & Development, R&D Managers and Research Delivery Leads to support the collection and reporting of metrics to enable UKDTN and the Alzheimer’s Society Research Nurse Programme to monitor performance of these programmes.  This will include ongoing review of early phase trial metrics, MCI/dementia research activity metrics and submission of an annual report to the Alzheimer’s Society.
•  During periods where early phase workload is light, and capacity allows, support fellow UKDTN funded research delivery staff and local research teams to deliver later phase interventional MCI / dementia clinical trials.
•  Maintain health, safety and security of self and others in own work area through ensuring own and others’ knowledge of relevant local / national policies, procedures and regulatory requirements and that these are adhered to.
•  Work according to the NMC Code of Professional Conduct and relevant professional standards and guidelines at all times.
•  Promote peoples’ equity, diversity and rights, through ensuring that own and others’ practice is in the best interests of patients.
•  Develop own knowledge and expertise within the speciality / research field.
•  Organise diagnostic tests and provide interventional therapy for specific trial protocols with support and supervision as appropriate.